HPLC Purity: What the Number Actually Means

What High Performance Liquid Chromatography Measures

High performance liquid chromatography separates the components of a sample by pumping it through a column packed with a material that interacts differently with each compound present. Compounds that interact more strongly with the column material travel through more slowly; compounds that interact less strongly move through faster. Each compound exits the column at a different time, called its retention time, and a detector records its presence as it exits.

For peptides, the standard configuration is reverse-phase HPLC, where the column material is nonpolar and the mobile phase is a polar solvent system, typically water and acetonitrile with a small amount of trifluoroacetic acid. Peptides separate largely by hydrophobicity under these conditions, which makes reverse-phase HPLC well suited to distinguishing a target peptide from closely related synthesis byproducts, truncated sequences, and deletion variants.

The instrument itself is only half the method. A pump delivers the mobile phase at a controlled flow rate, an injector introduces a fixed volume of sample onto the column, and a detector, usually measuring UV absorbance, records what elutes and when. Every one of those settings is a variable an analyst chooses, which is part of why the same physical sample can produce a slightly different trace on two different instruments, a point covered in more detail further on.

Reading a Chromatogram

The output of an HPLC run is a chromatogram: a plot of detector signal against time. Each compound that passes the detector produces a peak, and the position of that peak on the time axis is its retention time. A clean chromatogram for a well-purified peptide shows one large, sharp, symmetric peak with only small peaks elsewhere in the trace.

The area under each peak is proportional to how much of that compound was detected, not to how much is inherently present in absolute terms, since detector response can vary by compound. Analysts calculate purity as peak area percent: the area of the main peak divided by the total area of all peaks in the chromatogram, expressed as a percentage. A 98% purity result means the main peak accounted for 98% of the total detected peak area in that specific run, not that 98% of the total mass in the vial is confirmed to be the target peptide by every possible measure.

Purity Is Relative, Not Absolute

This is the core distinction buyers miss. Peak area percent compares the main compound against everything else the detector saw elute from the column under those specific conditions. It is not an absolute measurement of composition, and it depends entirely on what the detector was capable of seeing during that run.

If an impurity does not absorb light at the wavelength being monitored, does not separate cleanly from the main peak, or elutes outside the window the analyst recorded, it will not show up in the calculation at all, and the reported purity will read higher than the true composition of the sample. A 99% figure means 99% of what the method detected was the main peak. It does not mean the sample is 99% pure by every conceivable analytical measure, and it is not the same statement as net peptide content, which is a separate figure entirely.

What 95%, 98%, and 99% Do and Do Not Tell You

Higher peak area percent generally indicates a cleaner separation and fewer detectable synthesis byproducts, and it is a legitimate point of comparison between two reports run under similar conditions. That much the number is good for.

What it does not tell you: it does not confirm the compound is the correct peptide, since a clean chromatogram can still be a clean chromatogram of the wrong molecule if no separate identity test was performed. It does not state how much of the vial's total mass is peptide versus water or counter-ion salt, which is what net peptide content addresses instead. It says nothing about endotoxin level, and it says nothing about sterility. Purity by HPLC is one data point among several a complete Certificate of Analysis should provide, not a summary of all of them.

Why HPLC Purity Does Not Confirm Identity

Identity and purity are tested by different instruments answering different questions, and this bears repeating because it is the single most common confusion in how buyers read these reports. HPLC separates compounds by their physical interaction with a column and reports how much of the detected signal belongs to the main peak. It does not measure molecular mass and cannot, on its own, confirm what that main peak actually is.

Mass spectrometry is the method that confirms identity, by measuring the mass-to-charge ratio of the compound and comparing it against the expected mass for the intended sequence. A complete COA for something like GHK-Cu, BPC-157, or CJC-1295 should show a purity result from HPLC alongside a mass result from mass spectrometry confirming the observed mass matches the expected mass for that specific peptide. A report showing only an HPLC trace, however clean, has not established identity.

Gradient and Column Conditions: Why Two Labs Can Disagree

HPLC results are not produced under one universal, standardized set of conditions, and this is why two laboratories can report different purity figures for the same physical material without either one being wrong. The column's stationary phase, its length and particle size, the gradient profile of the mobile phase over the course of the run, the flow rate, and the run temperature all affect how well closely related compounds separate from the main peak.

A faster gradient or a shorter column can cause two compounds that would otherwise separate into distinct peaks to co-elute, meaning they exit the column at nearly the same time and register as a single peak. Co-eluting impurities inflate the apparent purity of the main peak because their area gets counted as part of it. A slower, more resolving method run on a longer column is more likely to separate those same compounds and report a lower, more conservative purity figure for identical material. Neither number is fabricated; they reflect different resolving power. This is one reason comparing purity figures across two COAs is only meaningful when the methods are reasonably similar.

Co-eluting impurities are also the reason a chromatogram is worth looking at directly rather than trusting the summary percentage alone. A peak that looks slightly broad, shouldered, or asymmetric on one side can be hiding a second compound underneath the main peak that integration software counted as a single peak. Analysts sometimes flag this by eye during review; a report that includes the actual trace, not just the final number, gives a buyer the chance to notice it as well.

Detection Wavelength: 214 nm vs. 280 nm

The detector in most HPLC systems used for peptide analysis is a UV absorbance detector, and the wavelength it monitors changes what it can see. Peptide bonds absorb strongly around 214 nm, which is why most peptide purity methods monitor at or near that wavelength: it detects the peptide backbone itself regardless of which amino acids are present.

Detection at 280 nm instead relies on absorbance from aromatic amino acid side chains, primarily tryptophan and tyrosine. A peptide that contains few or none of those residues will show a weak or negligible signal at 280 nm even if it is present in the sample at a normal concentration, which makes 280 nm detection unreliable for many peptide sequences and 214 nm the more common and broadly applicable choice. A COA that specifies 280 nm detection for a peptide with little aromatic content is worth a second look, since the method itself may be poorly matched to the compound.

How to Compare Two COAs Honestly

• Check whether the column type, gradient conditions, and detection wavelength are listed and comparable before treating one percentage as better than another
• Look for whether each report pairs HPLC purity with a mass spectrometry identity result
• Check whether net peptide content is reported separately from purity
• Note the test date and issuing laboratory on each report before weighing the numbers against each other

A fair comparison between two Certificates of Analysis starts with checking whether they used comparable methods, not with comparing the final percentages against each other. A COA with HPLC purity and mass spectrometry confirmation is more complete than one with HPLC purity alone, regardless of which percentage is higher. A peptide with 99% HPLC purity and a comparatively low net peptide content contains less actual peptide by mass than the two numbers together might suggest at a glance. The most informative comparison is never one percentage against another; it is method against method, and completeness against completeness.